News Alert

Novo Nordisk Files Suit to Block $100,000 Arkansas Fine for 340B Contract Pharmacy Violations

Novo Nordisk logo on building
Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.
Danish drug giant Novo Nordisk filed suit Thursday to stop a proposed $100,000 fine from Arkansas over alleged violations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Audit Finds Fourth Drugmaker Owes Refunds

Drugmaker RedHill Biopharma owes repayments to 340B covered entities, a finalized HRSA audit found.
A fourth drugmaker owes repayment to 340B covered entities, according to final audits posted this week by federal officials. RedHill [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Astellas Ends 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

Astellas Pharma
Astellas is the third drugmaker to loosen or end its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.
Drugmaker Astellas has ended its 340B contract pharmacy restrictions in both Arkansas and Louisiana in response to state laws that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmaker Overcharge Fines for 340B Drugs Reach Nearly $7,000

Drugmaker overcharge fines, which the Department of Health and Human Services assesses, recently increased to nearly $7,000.
The federal fine for each instance of drugmaker overcharges for 340B covered entities recently increased to nearly $7,000. The fine [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Post Refund Notices on HRSA Website

Drugmakers Noven and Granules each owe refunds to 340B providers, according to notices posted on HRSA's Office of Pharmacy Affairs website.
Noven Pharmaceuticals and Granules Pharmaceuticals owe refunds to 340B providers, according to notices posted on the Health Resources and Services [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

BMS Expands 340B Contract Pharmacy Conditions, Including for Grantees

Bristol Myers Squibb
Bristol Myers Squibb has announced updates to its conditions on pharmaceutical sales involving contract pharmacies.
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, effective Nov. 1. BMS outlined [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Offering 340B Refunds on Two Diagnostic Radiopharmaceuticals

Novartis wordmark on a building
Drugmaker Novartis is offering refunds to 340B covered entities on certain purchases of two radiopharmaceuticals.
Drug manufacturer Novartis is offering 340B covered entities refunds on purchases of two imaging agents, partly contingent on whether an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Major Drugmakers Agree to Negotiate Drug Prices with Medicare

Judge Michael Newman of the U.S. District Court for the Southern District of Ohio denied a business group's request to pause Medicare negotiations while legal challenges to the IRA play out.
Medicare drug price negotiations will move ahead as planned after major drugmakers agreed to participate and a federal district judge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eisai Adopts 340B Contract Pharmacy Restrictions, Pfizer and GSK Update Their Limits

Eisai contract pharmacy
Drugmaker Eisai's 340B hospital contract pharmacy restrictions will not apply to Arkansas and Louisiana providers.
Japanese pharmaceutical manufacturer Eisai will restrict 340B pricing on six drugs when dispensed by hospitals’ contract pharmacies. It is the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie Joins Legal Battle Over Louisiana’s 340B Contract Pharmacy Law

AbbVie headquarters
Hospital groups urged a federal district court to dismiss drugmaker AbbVie's lawsuit against Lousiana's 340B contract pharmacy law.
Drugmaker AbbVie has sued Louisiana over its 340B contract pharmacy law, joining a series of drug industry suits that challenge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report